Terms: = Endocrine gland cancer AND CCND1, BCL1, 595, ENSG00000110092, PRAD1, U21B31, D11S287E
312 results:
1. A Study on the Retrospective Reinterpretation of BRCA1 and BRCA2 Variants.
Kim JJ; Kim DJ; Nam EJ; Song KE; Ham JY; Kim YK; Lee NY
Clin Lab; 2024 Apr; 70(4):. PubMed ID: 38623660
[TBL] [Abstract] [Full Text] [Related]
2. Development and validation of prediction models for papillary thyroid cancer structural recurrence using machine learning approaches.
Wang H; Zhang C; Li Q; Tian T; Huang R; Qiu J; Tian R
BMC Cancer; 2024 Apr; 24(1):427. PubMed ID: 38589799
[TBL] [Abstract] [Full Text] [Related]
3. Trps1 predicts poor prognosis in advanced high grade serous ovarian carcinoma.
Wang X; Sun J; Liu Y; Lin Z; Jiang X; Ye Y; Lv C; Lian X; Xu W; Luo S; Liao S; Chen Z; Wang S
Int J Cancer; 2024 May; 154(9):1639-1651. PubMed ID: 38212905
[TBL] [Abstract] [Full Text] [Related]
4. Mental health and diet quality after primary treatment for ovarian cancer.
Johnston EA; Veenhuizen SGA; Ibiebele TI; Webb PM; van der Pols JC;
Nutr Diet; 2024 Apr; 81(2):215-227. PubMed ID: 38192229
[TBL] [Abstract] [Full Text] [Related]
5. Glucagon-Like Peptide-1 Receptor Agonists and Pancreatic cancer Risk in Patients With Type 2 Diabetes.
Dankner R; Murad H; Agay N; Olmer L; Freedman LS
JAMA Netw Open; 2024 Jan; 7(1):e2350408. PubMed ID: 38175642
[TBL] [Abstract] [Full Text] [Related]
6. [Diagnostic Value of American Thyroid Association Guidelines,American College of Radiology Thyroid Imaging Reporting and Data System,and Chinese Thyroid Imaging Reporting and Data System Alone and Combined With BRAF
Lin Y; Luo YK; Li J; Ren XY; Wang HW
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2023 Dec; 45(6):921-928. PubMed ID: 38173102
[TBL] [Abstract] [Full Text] [Related]
7. Clinical and Molecular Characteristics of Gonadotroph Pituitary Tumors According to the WHO Classification.
Carbonara F; Feola T; Gianno F; Polidoro MA; Di Crescenzo RM; Arcella A; De Angelis M; Morace R; de Alcubierre D; Esposito V; Giangaspero F; Jaffrain-Rea ML
Endocr Pathol; 2024 Mar; 35(1):1-13. PubMed ID: 38095839
[TBL] [Abstract] [Full Text] [Related]
8. The impact of surgical-oncologic textbook outcome in patients with stage I to III pancreatic ductal adenocarcinoma: A cross-validation study of two national registries.
Petruch N; Servin Rojas M; Lillemoe KD; Castillo CF; Braun R; Honselmann KC; Lapshyn H; Deichmann S; Abdalla TSA; Hummel R; Klinkhammer-Schalke M; Tol KK; Zeissig SR; Keck T; Wellner UF; Qadan M; Bolm L
Surgery; 2024 Apr; 175(4):1120-1127. PubMed ID: 38092633
[TBL] [Abstract] [Full Text] [Related]
9. [A single-center study on the oncological outcomes of active surveillance of thyroid nodules measuring≤1 cm with highly suspicious ultrasound features].
Liu CH; Zhao H; Xia Y; Cao Y; Zhang LY; Zhao Y; Gao LY; Liu RF; Liu YW; Liu HF; Meng ZL; Liu SZ; Lu Y; Palashate Y; Li XY
Zhonghua Yi Xue Za Zhi; 2023 Oct; 103(40):3186-3192. PubMed ID: 37879872
[No Abstract] [Full Text] [Related]
10. Network Pharmacological Analysis and Experimental Validation of the Effects of Silybin on Proliferation, Migration, and Immunotherapy of Papillary Thyroid cancer.
Xie W; Li H; Lin Q; Ke N
Endocr Metab Immune Disord Drug Targets; 2024; 24(6):672-690. PubMed ID: 37855349
[TBL] [Abstract] [Full Text] [Related]
11. FLNA expression modulates pathological markers of pituitary neuroendocrine tumours.
Toledo J; Perez PA; Zanetti M; Díaz-Torga G; Mukdsi JH; Gutierrez S
J Endocrinol; 2024 Jan; 260(1):. PubMed ID: 37855268
[TBL] [Abstract] [Full Text] [Related]
12. The cost-effectiveness analysis of maintenance olaparib plus Bevacizumab in patients with advanced ovarian cancer: based on the final survival results from PAOLA-1 trial.
Zhu Y; Liu K; Cao H; Zhu H
J Ovarian Res; 2023 Aug; 16(1):168. PubMed ID: 37605274
[TBL] [Abstract] [Full Text] [Related]
13. The auxiliary diagnosis of thyroid echogenic foci based on a deep learning segmentation model: A two-center study.
Liu Y; Chen C; Wang K; Zhang M; Yan Y; Sui L; Yao J; Zhu X; Wang H; Pan Q; Wang Y; Liang P; Xu D
Eur J Radiol; 2023 Oct; 167():111033. PubMed ID: 37595399
[TBL] [Abstract] [Full Text] [Related]
14. Facilitation of Definitive cancer Diagnosis With Quantitative Molecular Assays of BRAF V600E and TERT Promoter Variants in Patients With Thyroid Nodules.
Fu G; Chazen RS; Monteiro E; Vescan A; Freeman JL; Witterick IJ; MacMillan C
JAMA Netw Open; 2023 Jul; 6(7):e2323500. PubMed ID: 37505499
[TBL] [Abstract] [Full Text] [Related]
15. PARP inhibitor predictive value of the Leuven HRD test compared with Myriad MyChoice CDx PLUS HRD on 468 ovarian cancer patients from the PAOLA-1/ENGOT-ov25 trial.
Loverix L; Vergote I; Busschaert P; Vanderstichele A; Venken T; Boeckx B; Harter P; Brems H; Van Nieuwenhuysen E; Pignata S; Baert T; Gonzalez-Martin A; Han S; Marth C; Neven P; Colombo N; Berteloot P; Mäenpää J; Olbrecht S; Laga T; Sablon E; Ray-Coquard I; Pujade-Lauraine E; Lambrechts D; Van Gorp T
Eur J Cancer; 2023 Jul; 188():131-139. PubMed ID: 37245441
[TBL] [Abstract] [Full Text] [Related]
16. Sporadic parathyroid adenoma: an updated review of molecular genetics.
Chorti A; Cheva A; Chatzikyriakidou A; Achilla C; Boulogeorgou K; Despoina K; Milias S; Zarampoukas T; Papavramidis T
Front Endocrinol (Lausanne); 2023; 14():1180211. PubMed ID: 37223014
[TBL] [Abstract] [Full Text] [Related]
17. Identification of BRAF, ccnd1, and MYC mutations in a patient with multiple primary malignant tumors: a case report and review of the literature.
Liu Z; Jin C; Zhang Y; Jiang Y; Wang J; Zheng L
World J Surg Oncol; 2023 May; 21(1):158. PubMed ID: 37221610
[TBL] [Abstract] [Full Text] [Related]
18. Osteocalcin modulates parathyroid cell function in human parathyroid tumors.
Verdelli C; Tavanti GS; Forno I; Vaira V; Maggiore R; Vicentini L; Dalino Ciaramella P; Perticone F; Lombardi G; Corbetta S
Front Endocrinol (Lausanne); 2023; 14():1129930. PubMed ID: 37065733
[TBL] [Abstract] [Full Text] [Related]
19. Anticancer Effect of Active Component of Astragalus Membranaceus Combined with Olaparib on Ovarian cancer Predicted by Network-Based Pharmacology.
Liu Y; Guo Z; Lang F; Li J; Jiang J
Appl Biochem Biotechnol; 2023 Nov; 195(11):6994-7020. PubMed ID: 36976504
[TBL] [Abstract] [Full Text] [Related]
20. Long noncoding RNA CASC9 promotes pancreatic cancer progression by acting as a ceRNA of miR-497-5p to upregulate expression of ccnd1.
Zhou J; Song G; Su M; Zhang H; Yang T; Song Z
Environ Toxicol; 2023 Jun; 38(6):1251-1264. PubMed ID: 36947456
[TBL] [Abstract] [Full Text] [Related]
[Next]
